A detailed history of Tb Alternative Assets Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Tb Alternative Assets Ltd. holds 266,165 shares of NVO stock, worth $12.9 Million. This represents 2.4% of its overall portfolio holdings.

Number of Shares
266,165
Holding current value
$12.9 Million
% of portfolio
2.4%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

BUY
$45.68 - $59.65 $12.2 Million - $15.9 Million
266,165 New
266,165 $12.9 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tb Alternative Assets Ltd. Portfolio

Follow Tb Alternative Assets Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tb Alternative Assets Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Tb Alternative Assets Ltd. with notifications on news.